METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Clinical trials for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug avasopasem joins fight against metastatic breast cancer
Disease control Recruiting nowThis early-stage trial tests whether adding avasopasem to standard hormone therapy and a CDK4/6 inhibitor can help women with metastatic hormone receptor-positive breast cancer that has stopped responding to treatment. The study will enroll 35 participants and focus on safety, wh…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Morning or evening? new study tests best time for cancer pill.
Knowledge-focused Recruiting nowThis pilot study is testing whether taking endocrine therapy in the morning or evening makes a difference for people with metastatic breast or prostate cancer. Fifty participants will be randomly assigned to take their medication either within an hour of waking or within an hour …
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE4 • Sponsor: Ottawa Hospital Research Institute • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Blood test monitoring may be as good as scans for breast cancer patients
Knowledge-focused Recruiting nowThis study is testing whether using simple blood tests to decide when to do scans is as effective as the usual approach of regular scans for people with advanced breast cancer. About 739 participants will be randomly assigned to either blood test monitoring or standard care. The …
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC